Actively Recruiting

Age: 18Years +
All Genders
NCT07504146

The Orienting Study

Led by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Updated on 2026-03-31

450

Participants Needed

1

Research Sites

782 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study at IRCCS Galeazzi - Sant'Ambrogio Hospital involves patients with gout, CPPD, and osteoarthritis as a control group. Patients will receive routine care with regular clinical, laboratory, and imaging assessments every six months, alongside urgent visits as needed. The study aims to understand crystal deposits in joints and blood vessels and monitor their progression over time, assessing how these deposits respond to standard treatments and if they are associated with cardiovascular complications. Data will be collected from medical records over a follow-up period of up to 10 years, offering long-term insights into disease impact and treatment effectiveness.

CONDITIONS

Official Title

The Orienting Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with CPPD disease according to the ACR/EULAR 2023 classification criteria
  • Patients with evidence of asymptomatic CPPD on ultrasound or X-rays, not meeting classification criteria, per validated imaging definitions
  • Patients diagnosed with gout according to the ACR/EULAR 2015 classification criteria
  • Patients diagnosed with osteoarthritis (OA) per ACR classification criteria as disease controls
  • Disease controls must have no evidence of uric acid or calcium pyrophosphate deposits on ultrasound
  • Disease controls must have uric acid less than 6 mg/dL
  • All participants must be older than 18 years
  • Able to provide informed consent as required by the local ethics committee
Not Eligible

You will not qualify if you...

  • Known history of other inflammatory arthropathies for gout/CPPD patients
  • Known history of other inflammatory arthropathies for disease controls
  • Unable to provide informed consent according to local ethics committee requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Ospedale Galeazzi-Sant'Ambrogio

Milan, Milano, Italy, 20157

Actively Recruiting

Loading map...

Research Team

G

Georgios Filippou, MD

CONTACT

S

Silvia Sirotti, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here